oncology » Trang Công Nghệ | Trangcongnghe.vn

Io Therapeutics, Inc., announces presentation of data on its RAR gamma agonist compound IRX5010 demonstrating inhibition of tumor infiltrating myeloid derived suppressor cells, promotion of tumor infiltrating T-cells, and effective tumor growth inhibition

Globe Newswire

Io Therapeutics, Inc., announces presentation of data on its RAR gamma agonist compound IRX5010 demonstrating inhibition of tumor infiltrating myeloid derived suppressor cells, promotion of tumor infiltrating T-cells, and effective tumor growth inhibition

Boehringer Ingelheim expands cancer research at its Vienna site

Globe Newswire

Boehringer Ingelheim expands cancer research at its Vienna site

Globe Newswire

Boehringer’s zongertinib shows encouraging efficacy and tolerability profile in previously treated HER2 mutated lung cancer patients

Boehringer Ingelheim to unveil groundbreaking oncology research at WCLC, demonstrating strength of portfolio

Globe Newswire

Boehringer Ingelheim to unveil groundbreaking oncology research at WCLC, demonstrating strength of portfolio

Reneo Pharmaceuticals and OnKure Announce Proposed Merger

Globe Newswire

Reneo Pharmaceuticals and OnKure Announce Proposed Merger